Gracell Biotechnologies I...

NASDAQ: GRCL · Real-Time Price · USD
10.25
0.01 (0.05%)
At close: Feb 21, 2024, 10:00 PM

Gracell Biotechnologies Cash Flow Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
-4.16B -451.75M
Depreciation & Amortization
531.08M 60.27M
Stock-Based Compensation
165.15M 60.38M
Other Working Capital
n/a n/a
Other Non-Cash Items
55.97M 1.3M
Deferred Income Tax
n/a n/a
Change in Working Capital
103.34M 25.26M
Operating Cash Flow
-3.31B -304.55M
Capital Expenditures
-331.55M -56.74M
Cash Acquisitions
1.79B 10M
Purchase of Investments
-1.79B -10M
Sales Maturities Of Investments
1.79B 25.13M
Other Investing Acitivies
-1.79B -10M
Investing Cash Flow
-331.17M -41.62M
Debt Repayment
n/a n/a
Common Stock Repurchased
n/a n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
228.34M 1.46B
Financial Cash Flow
228.34M 1.46B
Net Cash Flow
-2.57B 1.07B
Free Cash Flow
-3.64B -361.29M